To test the hypothesis that NAM plays a key role in suppressing lung cancer growth through the ferroptosis program, we analyzed cell composition changes by detecting cellular mitochondrial ferrous ions, ROS, MDA, PUFA, and GSH after over- or low-expression NAMPT with high-dose NMN treatment. The gene discussed is STAC3; the disease is lung cancer.